The studies of Munkacsi and coworkers [36] identified a significant up-regulation of HDAC4 in fibroblasts of NPC patients, along with HDAC6 and 11, which was markedly corrected by HDAC inhibition. This evidence concerns the gene HDAC9 and nasopharyngeal carcinoma.